This website uses cookies to improve functionality and performance. With a click on the OK button you are giving implied consent to the use of cookies on this website.
More information
Login Environment Pharma

Online access

 Our customers (e.g. CRAs, study directors, QA) may access the study-specific lab information featuring:

  • Information on all sites involved including performance indicators
  • Demographics of all patients
  • Lab results: lab reports can be viewed and printed
    -individually: PDF file for each visit
    -cumulatively: all visits at a glance
    -flexibly: using either SI or conventional units
  • Trend graphs show how each lab test develops during the study 
  • Abnormal results are shown in tables to simplify monitoring of test drug's safety: 
  • -in alphabetical order
  • -by level of seriousness: flagging criteria
  • Statistical overviews for global studies
  • Overview of unresolved queries to investigators: e.g. missing data
Contact us


View All
Fellbach wird neuer Laborstandort
Nach zweijähriger Planungs- und Umbauphase entstand in Fellbach das neue Labor der SYNLAB Analytics & Services Germany GmbH.
Aug 10, 2018 Continue
Determination of the Impurity N-Nitroso dimethyl amine (NDMA) in Drug Substances with GC-MS

Due to contamination of a drug substance with the potential mutagenic substance N-Nitroso dimethyl amine (NDMA) a massive recall campaign was initiated for the related drug products. SYNLAB Pharma offers a GC-MS test for testing the absence of NDMA in drug substances and drug products.

Please contact our experts.

Jul 13, 2018 | Pharma Continue
New Services in Regulatory Compliance for Biologics

With immediate effect, SYNLAB Pharma provides a broad support in the field of Regulatory Compliance of Biologics development. With this new services we support specifically start-ups, small to medium sized biotech companies, which require professional consultancy and project execution in regulatory project design.

For further questions, please contact:

Jun 18, 2018 | Pharma Continue
View All